iBTA-Induced Biotube® Blood Vessels: 2020 Update
Authors:
- Yasuhide NakayamaYasuhide Nakayama
- Ryuji HigashitaRHRyuji Higashita
- Yasuyuki ShiraishiYSYasuyuki Shiraishi
- Tadashi UmenoTUTadashi Umeno
- Tsutomu TajikawaTTTsutomu Tajikawa
- Akihiro YamadaAYAkihiro Yamada
- Kazuki MoriKMKazuki Mori
- Manami MiyazakiMMManami Miyazaki
- Mamiko OharaMOMamiko Ohara
- Ryosuke IwaiRIRyosuke Iwai
- Takeshi TerazawaTTTakeshi Terazawa
- Tomonori OieTOTomonori Oie
Open Access
- 17 June 2021
- journal article
- review article
- Published by MDPI AG in Kidney and Dialysis
- Vol. 1 (1) , 3-13
Abstract
Blood access is a lifeline for dialysis patients. However, serious problems such as stenosis or obstruction of access blood vessels, which are life-threatening conditions in daily clinical practice, still remain. One of the most promising candidates for solving these problems may be Biotube blood vessels. More than 20 years have passed since the development of in-body tissue architecture (iBTA), a technology for preparing tissues for autologous implantation in patients. The tissues obtained by iBTA do not elicit immunological rejection, which is one of the ultimate goals of regenerative medical engineering; however, their practical applications were quite challenging. The seemingly unorthodox iBTA concepts that do not follow the current pre-established medical system may not be readily accepted in general medicine. In contrast, there are many diseases that cannot be adequately addressed even with the latest and most advanced medical technology. However, iBTA may be able to save patients with serious diseases. It is natural that the development of high-risk medical devices that do not fit the corporate logic would be avoided. In order to actively treat such largely unattached diseases, we started Biotube Co., Ltd. with an aim to contribute to society. Biotubes induced by iBTA are collagenous tubular tissues prepared in the patient’s body for autologous implantation. The application of Biotubes as tissues for vascular implantation has been studied for many years. Biotubes may have excellent potential as small-diameter artificial blood vessels, one of the most difficult to clinically achieve. Their possibility is currently being confirmed in preclinical tests. Biotubes may save hundreds of thousands of patients worldwide annually from amputation. In addition, we aim to eliminate the recuring access vascular problems in millions of dialysis patients. This study provides an update on the current development status and future possibilities of Biotubes and their preparation molds, Biotube Makers.Keywords
This publication has 36 references indexed in Scilit:
- Urinary bladder reconstruction using autologous collagenous connective tissue membrane “Biosheet®” induced by in-body tissue architecture: A pilot studyRegenerative Therapy, 2020
- Mechanical characterization of an in-body tissue-engineered autologous collagenous sheet for application as an aortic valve reconstruction materialJournal of Biomechanics, 2020
- Fabrication of an anatomy-mimicking BIO-AIR-TUBE with engineered cartilageRegenerative Therapy, 2019
- Long-term outcomes of patch tracheoplasty using collagenous tissue membranes (biosheets) produced by in-body tissue architecture in a beagle modelSurgery Today, 2019
- One-year follow-up study of iBTA-induced allogenic biosheet for repair of abdominal wall defects in a beagle model: a pilot studyHernia, 2018
- Tracheal Replacement Using an In-Body Tissue-Engineered Collagenous Tube “BIOTUBE” with a Biodegradable Stent in a Beagle Model: A Preliminary Report on a New TechniqueEuropean Journal of Pediatric Surgery, 2018
- iBTA-induced bovine Biosheet for repair of abdominal wall defects in a beagle model: proof of conceptHernia, 2018
- Patch esophagoplasty using an in-body-tissue-engineered collagenous connective tissue membraneJournal of Pediatric Surgery, 2018
- Engineering and repair of diaphragm using biosheet (a collagenous connective tissue membrane) in rabbitsJournal of Pediatric Surgery, 2018
- In-body tissue-engineered collagenous connective tissue membranes (BIOSHEETs) for potential corneal stromal substitutionJournal of Tissue Engineering and Regenerative Medicine, 2013